Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

DigitalOcean’s AI Potential: A Game-Changer for Growth

DigitalOcean's outlook is improving and creating a catalyst for this undervalued, underappreciated AI play. Growth has stabilized and is expected to accelerate.

MarketBeat

Supercharge Your Portfolio With These 3 Key Stocks

Now that 2025 is underway, investors might want to consider the best potential risk-to-reward ratios in the market to supercharge their portfolios.

MarketBeat

Tide Shifts for 3M: How to Profit from the Rally

3M stock is melting up on improving results and cash flow. Cash allowed for healthy, reliable dividends and robust buybacks.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Palantir Technologies: Another Stellar Year Ahead for the Stock?

Palantir Technologies became the S&P 500's top performer in 2024, with its stock surging 340%, however concerns now exist over a stretched valuation.

MarketBeat

2 ETFs to Maximize Gains With Covered Call Strategies

The ISPY and IQQQ ETFs generate high income yields by executing a daily covered call strategy in the benchmark indexes to collect premiums and dividend yields.

MarketBeat

3 Small-Cap Stocks Insiders and Institutions Are Buying

Insiders and institutions bought B&GFoods, Archer Aviation, and Wolfspeed in Q4 2024; are these good stocks to buy for 2025? T

MarketBeat

MaxCyte: Building the Future of Cell and Gene Therapy Innovation

MaxCyte's proprietary Flow Electroporation technology enables companies like Vertex and CRISPR Therapeutics to get FDA approved for their gene-editing therapy.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Oracle Announces Game-Changing News for the AI Industry

Oracle had a game-changing year, establishing itself as a leading player in AI infrastructure and services. The growth and dividend outlook is improving.

MarketBeat

Netflix Adds 19 Million Subscribers, Growth Is Far From Over

Netflix shares surged post earnings after the company posted its largest subscriber gains of all time. Shares of Netflix still show upside in 2025 and beyond.

MarketBeat

Tempus AI: A Game-Changer in AI-Powered Healthcare

TEM surged 35% on Tuesday, fueled by the launch of its AI-powered health app Olivia and news of Nancy Pelosi's disclosed call option position in the stock.

MarketBeat

Pelosi Bets Big on AI: This Is What You Need to Know

Congressional Whale Nancy Pelosi is in the spotlight, buying significant positions in tech stocks like NVDA and other AI plays.

MarketBeat

Mobileye's High Short Interest Signals Squeeze Potential

Mobileye is well-positioned within the autonomous driving industry and can take share while deepening penetration with OEMs globally.

MarketBeat

Rivian: Weathering the Storm, Poised for Growth?

Rivian's initial Q4 results, DOE loan, strategic partnerships, and innovative technology position the company for substantial growth in the dynamic EV market.

MarketBeat

Avient Stock: Manufacturing Play With Double-Digit Upside

Analysts have recently boosted their outlooks on this stock, mixing their bullish expectations for the manufacturing and transportation sectors.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play

GLP-1 drugs have been all the rage for weight loss, but GE Healthcare and Novo Nordisk are working on a non-invasive approach to controlling metabolic functions

MarketBeat

Super Micro Computer: Turning Risk Into Reward at the Crossroads

Investors might now wonder whether Super Micro Computer stock is a potential buy at the lows, writing off the tail risk of recent bearish momentum.

MarketBeat

After a Reset Year, Is Moderna Stock Poised for a Comeback?

Moderna had a rough 2024 and is starting 2025 with lowered forecasts, but is focused on getting 10 FDA approvals in the next three years. Is now time to buy?

MarketBeat

Retail Trends Spark Analyst Upgrades for DICK's Sporting Goods

After a recent macroeconomic data report on retail sales, Wall Street analysts found enough reason to boost a stock in a winning industry.

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Teck Resources: America’s Ally in Rare Earth Elements

China's ban on certain rare earth mineral exports to the United States bolsters the importance of Teck Resources as an ally in the rare earth supply chain.

MarketBeat

Best Buy's Dividend Is a Bargain With Double-Digit Upside

Best Buy stock offers investors the opportunity to have double-digit upside and an attractive dividend income for the coming months.

MarketBeat

SAP’s Strong Momentum: A Bullish Setup for Investors

With just three weeks gone of the new year, 2025 is already shaping up to be another banner year for SAP. Let's jump in and take a look.

MarketBeat

BlackRock Breaks Records: Why the Stock Still Has Room to Run

The world's largest asset manager BlackRock continued to grow the amount of cash investors entrust with it, breaking records. It is poised for more growth.

MarketBeat

Duke vs. NRG: Which Energy Stock Will Power Higher Gains?

Electric utility stocks were hot in 2024, but which stocks will continue to be strong in 2025? Duke Energy or NRG Energy, regulated or deregulated markets?

MarketBeat

Gold's Momentum Persists: Leading ETF and 2 Stocks to Watch

Gold's 2024 outperformance has carried over into 2025, with GLD up nearly 3% year-to-date and several gold stocks displaying immense relative strength.

MarketBeat

Tesla Cybertruck Discounts: What They Mean for the Stock Price

Tesla stock is trading near a critical resistance level that could be a hard ceiling for the stock price in 2025. Analysts are hopeful but institutions sell.

1 … 90 91 92 93

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.